About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, October 30th, 2013

The QualityStocks
Daily Stock List


PuraMed BioScience, Inc. (PMBS)

PennyStocks24 reported earlier on PuraMed BioScience, Inc. (PMBS), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.

Based in in Schofield, Wisconsin, PuraMed BioScience, Inc. is a researcher, developer, and marketer of Over-The-Counter (OTC; non-prescription) medicinal and healthcare products. The Company is a pharmaceutical enterprise dedicated to the development, testing, and marketing of safe, highly effective, healthcare products. PuraMed emphasizes science as a vital component for the Company’s success. Concerning their initial product line, they use a unique sublingual (under the tongue) delivery system. PuraMed BioScience’s shares trade on the OTC Markets’ OTCQB.

PuraMed BioScience has their homeopathic formulation LipiGesic® M product. It provides acute relief from migraine headaches. LipiGesic® M is an OTC formulation of feverfew and ginger. It has been clinically tested and found to provide quick relief from migraine headache and associated symptoms.

LipiGesic® M is a sublingually delivered gel. One pre-measured dose is squeezed under the tongue at the first sign of migraine and held in place for one minute. After five minutes, another pre-measured dose is administered the same way. Sublingual (under the tongue) administration is a delivery method, which permits substances to be absorbed directly into the blood vessels and lymphatics of the mouth. These allow the medication to be absorbed fast.

In addition, PuraMed BioScience plans to launch LipiGesic® H for tension-type headaches and LipiGesic PM, which provides relief from insomnia and other sleep disorders.

In June 2013, PuraMed BioScience announced the science behind LipiGesic® M. They started the formulation process by means of the laboratory method and in-vitro analysis. Through simulating an inflammatory response similar to the inflammation experienced by people with migraine, PuraMed was able to test the effectiveness of LipiGesic® M’s active ingredients.

The resulting in-vitro analysis showed a near total inhibition of both nitrous oxide synthesis and nuclear factor kappa beta. These were important findings since nitrous oxide and nuclear factor kappa beta have been shown to play significant roles in the development of inflammation and the development of migraine pain and associated symptoms.

PuraMed BioScience, Inc. (PMBS), closed Wednesday's trading session at $0.0075, up 11.94%, on 8,200 volume with 2 trades. The average volume for the last 60 days is 16,308 and the stock's 52-week low/high is $0.005/$0.0129.

Celator Pharmaceuticals, Inc. (CLPM)

Today we are reporting on Celator Pharmaceuticals, Inc. (CLPM), here at the QualityStocks Daily Newsletter.

Celator Pharmaceuticals, Inc. is a pharmaceutical company developing new and more effective therapies to treat cancer. The Company’s mission is to improve and extend the lives of patients with cancer through discovering and developing novel products based on their CombiPlex® technology (their proprietary technology platform). CombiPlex® introduces for the first time, the ability to collect in vitro drug combination informatics and apply those findings directly to the development of new clinically viable drug products.

Celator Pharmaceuticals’ shares trade on the OTC Markets OTCQB. Founded in 2000, the Company has locations in Ewing, New Jersey, and Vancouver, British Columbia. Celator’s lead product candidates are targeting acute myeloid leukemia and colorectal cancer. A preclinical program is exploring potential drug candidates for other tumor types.

CombiPlex® is Celator’s proprietary drug ratio technology platform. It represents a novel approach, which identifies molar ratios of drugs that will deliver a synergistic benefit, and locks the desired ratio in a nano-scale drug delivery vehicle that maintains the ratio in patients with the goal of improving clinical outcomes.

Celator Pharmaceuticals’ pipeline includes two clinical stage products, CPX-351 (a liposomal formulation of cytarabine: daunorubicin) for the treatment of acute myeloid leukemia and CPX-1 (a liposomal formulation of irinotecan: floxuridine) for the treatment of colorectal cancer. In addition, the Company’s pipeline includes preclinical stage product candidates, including CPX-571 (a liposomal formulation of irinotecan: cisplatin), and the hydrophobic docetaxel prodrug nanoparticle (HDPN) formulation undergoing study by the National Cancer Institute’s Nanotechnology Characterization Laboratory.

Last month, Celator Pharmaceuticals announced that the first patient enrolled in an investigator-initiated clinical study evaluating CPX-351 (cytarabine: daunorubicin) Liposome Injection in pediatric, adolescent, and young adult patients with relapsed or refractory hematologic malignancies. The study will take place in two phases: a dose exploration phase and an expanded phase. The study will assess the pharmacokinetics, tolerability, and early evidence of efficacy of CPX-351 in pediatric, adolescent, and young adult patients with relapsed or refractory hematologic malignancies.

Celator Pharmaceuticals, Inc. (CLPM), closed Wednesday's trading session at $3.15, down 16.00%, on 112,500 volume with 29 trades. The average volume for the last 60 days is 5,853 and the stock's 52-week low/high is $3.40/$6.00.

Liberated Energy, Inc. (LIBE)

Real Pennies reported earlier on Liberated Energy, Inc. (LIBE), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Headquartered in Marlton, New Jersey, Liberated Energy, Inc. is a developer of alternative energy products and technologies. They established to bring affordable alternative energy to the marketplace. Currently, the Company has a patent pending for a ridgeline roof wind device. Liberated Energy’s initial goal is to make small wind and solar turbine technology a major contributor to the global clean energy supply portfolio through providing consumers with an affordable renewable energy option for their homes and businesses. Liberated Energy lists on the OTCQB.

Liberated Energy is waiting for patent approval for the Company’s horizontal ridge wind turbine. The Company is in the process of patenting their home security system. This system will not require conventional electricity and can be run by a smart phone. Furthermore, Liberated Energy has been working for some time on utilizing plasma with hydrocarbons; they have delivered very strong results. This technology extracts oil, carbons, as well as other reusable materials, from trash and tires that were otherwise disposed into landfills.

Liberated Energy indicates that their technology should offer every homeowner the chance to generate the majority of his or her monthly electrical requirements. With the Company’s novel design, the turbine and housing will be aesthetically pleasing and will tie in with existing architecture. Liberated Energy acquired the patent rights from Perpetual Wind Power Corp. (PWPC) to their ridgeline roof wind device. PWPC has applied for a U.S. patent.

In September, Liberated Energy announced that they entered into agreements for sales of the Company’s patent-pending Ridgeline Roof Wind Turbine. The basis of the units will be on the design for their existing prototype.

Moreover, in September, Liberated Energy announced that they retained their first ever investment banking firm (Street Capital); they are pursuing a $5 million dollar financing deal. Having Street Capital involved will permit Liberated Energy to fulfill future orders and additionally help with production and marketing for the upcoming innovative products that will be brought to the marketplace.

Liberated Energy, Inc. (LIBE), closed Wednesday's trading session at $0.1499, up 24.92%, on 21,000 volume with 5 trades. The average volume for the last 60 days is 56,767 and the stock's 52-week low/high is $0.0211/$5.00.

Sterling Consolidated Corp. (STCC)

OTCBB Journal, First Penny Picks, OTPicks, and Equity Observer reported today on Sterling Consolidated Corp. (STCC), PennyStocks24, Pumps and Dumps, MyBestStockAlerts, Fast Money Alerts, Penny Stock General, Stock Shock and Awe, Mad Money Picks did earlier, and we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Sterling Consolidated Corp., by way of their wholly-owned subsidiary, Sterling Seal and Supply, has been a foremost supplier of hydraulic and pneumatic seals to the automotive and industrial marketplace for more than 40 years. Sterling Consolidated has their corporate headquarters in Neptune, New Jersey. The Company lists on the OTCQB.

Sterling Consolidated’s intention is to be an active and strategic consolidator of small- and mid-sized businesses within the highly-fragmented, multi-billion dollar seal industry. The Company presently serves over 3,000 customers. Sterling offers acquisition targets a unique growth opportunity and competitive advantage by way of logistical expertise, strong regional branding, and industry-specific distribution centers.

At the beginning of this month, Sterling Consolidated announced that the Company has fully integrated their most recent acquisition, Superior Seals and Service. The acquisition of Superior Seals and Services provides Sterling with an increased customer base and expedited delivery options to new and existing customers. Sterling has integrated their business and accounting procedures with their new strategic North Carolina location, since the purchase of their recent acquisition. This integration has exposed established customers to new products. This has led to greater revenue and enhanced service with new business stemming from Sterling's accounts.

Today, Sterling announced that their Acquisition Committee has accelerated the negotiations of the Company’s next acquisition target as Sterling looks to further consolidate the highly fragmented O-ring distributor market. The Acquisition Committee has increased their efforts, following their initial acquisition of Superior Seals and Service, as Sterling continues to position their company as a growing and leading supplier of hydraulic and pneumatic seals.

Mr. Darren DeRosa, Chief Executive Officer of Sterling Consolidated, commented, "With our first acquisition completed, sooner than expected, we are continuing to execute on our business plan. We are aggressively structuring deals with additional O-ring distributors that will help expand Sterling's footprint. We have targeted several regionally strategic and well run companies along the East Coast, as we are intent on rapidly growing our Company."

Sterling Consolidated Corp. (STCC), closed Wednesday's trading session at $0.155, up 3.33%, on 558,490 volume with 93 trades. The average volume for the last 60 days is 28,781 and the stock's 52-week low/high is $0.15/$0.30.

Intelligent Living, Inc. (ILIV)

PennyStocks24, Pumps and Dumps, Penny Stock Rumble, Stock Roach, and StockHideout reported recently on Intelligent Living, Inc. (ILIV), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTCQB, Intelligent Living, Inc. operates as a development stage company. They focus on the ever-expanding age management and wellness markets. Headquartered in Florida, the Company is a health and wellness enterprise involved in the development of software and technology to aid in age management and cognitive health. Intelligent Living’s corporate mission is to improve a person's quality and function of daily living over a span of many years.

The Company’s markets include exercise, nutrition, supplements, mental acuity testing and training, via their newly acquired subsidiary MIND360, in addition to hormone replacement therapy. In September, Intelligent Living announced the establishment of the Company’s platform for researching and further development of products and services in their already recognized MIND360.com brain games. The platform is named MIND360 Studios. It will become the grouping of experts, designers, and scientists within the world of gaming and social science with the goal of developing and designing edugames for ADHD, PTSD, and emotional distress.

Today, Intelligent Living announced that they tendered a Letter of Intent (LOI) with Health and Beyond, LLC (a company headquartered out of South Florida and founded in 1999) to acquire their business, formularies, as well as customer base. Health and Beyond's team of professional holistic physicians, medical doctors, chiropractors, naturopaths, and researchers work jointly to constantly develop distinctive formulations that specifically target unsolved health problems. Intelligent Living is going to look at building some very sizable ecommerce platforms as well as launch some premier branding around Dr. Larry LeGunn and the Health and Beyond label.

Victoria Rudman, Chief Executive Officer of Intelligent Living, said, "When we looked at the marketplace and saw Health and Beyond LLC and Dr. Larry LeGunn, we knew that we had come across an undervalued gem. Dr. Larry LeGunn has been in practice for 35 years and has retired as of 2011. He has devoted all his efforts in perfecting unique nutraceuticals to help humanity. This partnership will allow us to quickly add some great products as well as an incredible brand to the Intelligent Living family, which we will take with us on our global journey."

Intelligent Living, Inc. (ILIV), closed Wednesday's trading session at $0.0014, up 16.67%, on 100,952,185 volume with 252 trades. The average volume for the last 60 days is 6,809,908 and the stock's 52-week low/high is $0.0001/$0.05.

Bison Petroleum Corp. (BISN)

The Trading Report reported today on Bison Petroleum Corp. (BISN), Investors Alley, StreetAuthority Financial, Wyatt Investment Research, Insider Wealth Alert, Oakshire News Bulletin, and Dividend Opportunities reported this week, and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Bison Petroleum Corp. is an oil and gas Exploration and Development Company. Their dedication is to the exploration and development of domestic energy in the Bighorn Basin of Wyoming. The Company has acquired 840 acres of undeveloped prime acreage in this basin. Bison Petroleum’s shares trade on the OTC Markets’ OTCQB. The Company has their headquarters in Salt Lake City, Utah.

Bison has a 100 percent Working Interest (WI) and an 80 percent Net Revenue Interest (NRI) in the 840-acre Independence Prospect situated in the Bighorn Basin. The Company’s assets are close to established industry infrastructure. The vast majority of production in the Basin has come from margin anticline structures. These include the Oregon Basin, Elk Basin, Hamilton Dome, Grass Creek, as well as Garland fields. The Bighorn Basin has been a productive producer of oil and gas since the discoveries of the Basin’s first oil fields in the early 1900’s.

Today, Bison Petroleum provided a corporate update. The update includes further details on the Independence Prospect and the appointment of two experienced advisors. The Independence Prospect’s two leases offset Marathon Oil's 150 million barrel (MMBO) Spring Creek Field. These leases are less than 10 miles from the 475 MMBO Oregon Basin Field.

An independent report on the Independence Prospect's original acreage position, estimates the two leases are believed to have a potential of original oil in place (OOIP) of 135 MMBO and estimated ultimate recovery (EUR) of up to 27 MMBO (Independence Prospect Report, Dr. Stewart A. Jackson, Consulting Geologist, June 2013).

Bison Petroleum is now developing an exploration plan for these leases. It includes 2D seismic acquisition, a Seep Study, and 3D seismic to define optimized drilling locations in the targeted Lower Cretaceous Muddy Formation. The Company’s expectation is that the Muddy accumulations will be between 2,000' to 6,000' drilling depths; well spacing potential is 10 acres per well.

Bison Petroleum Corp. (BISN), closed Wednesday's trading session at $1.46, up 8.96%, on 289,438 volume with 246 trades. The average volume for the last 60 days is 31,820 and the stock's 52-week low/high is $0.035/$1.35.

Arch Therapeutics, Inc. (ARTH)

Pumps and Dumps reported this week on Arch Therapeutics, Inc. (ARTH), PennyStocks24, Wallstreet Profiler, Pennystocktweeters.com, Center Stage Stocks, Planet Penny Stocks, StockRunway, Buzz Stocks did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Arch Therapeutics, Inc. is a medical device company based in Wellesley, Massachusetts. The Company is developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch's aim is to develop and commercialize products founded on their ground-breaking technology platform that make surgery and interventional care faster and safer for patients. Arch Therapeutics’ shares trade on the OTCQB.

The underlying technology, exclusively licensed from a leading university, supports an innovative platform of smart materials that fulfill the criteria as a solution for a specialized field the Company calls, “stasis and barrier applications.” Arch Therapeutics’ flagship development stage product candidate known as AC5™ is undergoing design to sophisticatedly achieve hemostasis in minimally invasive ((laparoscopic) and open surgical procedures. Their solution elegantly controls the movement of fluids and substances.

AC5™ is a synthetic peptide consisting of naturally occurring amino acids. When squirted or sprayed onto a wound, AC5™ quickly intercalates into the nooks and crannies of the connective tissue where it builds itself into a physical, mechanical structure. That structure provides a barrier to leaking substances (including blood and other bodily fluids) regardless of kind of surgery or, based on early data, clotting ability, and healing occurs normally.

The Company indicates that in preclinical tests, AC5™ has been simple, effective, and versatile. So far, biocompatibility has been excellent and healing of tissue treated with the device has been normal. AC5™ stops bleeding promptly. AC5™ conforms to irregular wound geometry as well as helps in maintaining a clear field of vision directly into the wound area.

This month, Arch Therapeutics announced that the Massachusetts Life Sciences Center, a quasi-public agency tasked with implementing the State's $1 billion Life Sciences Initiative, concluded the necessary steps to award Arch Therapeutics with a $1 million dollar Accelerator Loan. The Accelerator Loan Program provides loans to companies engaged in life sciences research and development, commercialization, and manufacturing in Massachusetts.

Arch Therapeutics, Inc. (ARTH), closed Wednesday's trading session at $0.238, up 16.67%, on 309,196 volume with 76 trades. The average volume for the last 60 days is 360,609 and the stock's 52-week low/high is $0.0136/$1.36.

Energy Edge Technologies Corp. (EEDG)

PennyStocks24 reported earlier on Energy Edge Technologies Corp. (EEDG), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Founded in 2004, and listed on the OTCQB, Energy Edge Technologies Corp. is the parent company of Energy Edge Solutions and The Gourmet Wing Company. Energy Edge Solutions provides energy engineering and other services primarily for energy cost and consumption reduction in the U.S.  The Gourmet Wing Company specializes in bone-in and boneless, tender and juicy on the inside, super crispy on the outside wings, covered with a choice of their proprietary sauces.  

Energy Edge Solutions offers mid to large sized companies, institutions, and government entities with turnkey whole facility solutions, which reduce energy consumption, including electric, gas, fuel, and water; and improve the efficiency of new and existing equipment and buildings. Energy Edge Solutions’ customers include municipalities, breweries, pharmaceuticals, restaurants, food processing, manufacturing, printing, leisure, hospitals, office buildings, and more.

This past June, The Gourmet Wing Company jointly announced that they entered into a Joint Venture (JV) agreement with Mr. Alex Eboigbe and his brother, Mr. John Eboigbe, to significantly develop the brand presence in Atlanta, Georgia. Both men are experienced restaurant operators with over 30 years of experience between them. The Gourmet Wing Company is based in Atlanta, Georgia.

In addition, in June, Energy Edge Technologies’ Chief Executive Officer, Mr. James Boyd, reported on progress the Company has made since he assumed office. Highlights include the Company eliminating a substantial amount of debt produced by Energy Edge Solutions. Additionally, Energy Edge Technologies submitted an 8k detailing the executed modification agreement and now the Company owns 100 percent of Dry Fried Wings. Mr. Boyd is establishing deliverables connected to sales and profit projections for Energy Edge Solutions and the restaurant group. He noted that the Company will delay any spin-off until each entity has sufficient assets. A name change will follow shortly thereafter.

In September, Mr. Boyd announced that the Company will start implementation of a Three Step Strategic Plan. Energy Edge Technologies will amend their Bylaws creating several series of Anti-Dilutive Convertible Preferred Shares to protect their shareholders and attract new acquisitions which are currently in negotiations. The Company will also improve the Balance Sheet with aggressive debt reorganization techniques enabling them to become debt free as soon as is feasible. Energy Edge Technologies is aggressively looking for new acquisitions to align with their Strategic Plan. Additionally, the Company will acquire many assets through the use of the newly created Convertible Preferred Shares.

Energy Edge Technologies Corp. (EEDG), closed Wednesday's trading session at $0.0109, down 8.40%, on 439,700 volume with 9 trades. The average volume for the last 60 days is 379,177 and the stock's 52-week low/high is $0.007/$0.128.


The QualityStocks
Company Corner


On the Move Systems, Inc. (OMVS)

The QualityStocks Daily Newsletter would like to spotlight On the Move Systems, Inc. (OMVS). Today, On the Move Systems, Inc. closed trading at $0.061, up 1.67%, on 397,357 volume with 37 trades. The stock’s average daily volume over the past 60 days is 225,709, and its 52-week low/high is $0.0027/$0.403.

On the Move Systems, Inc. in its quest to discover new solutions to the growing demand for business jet travel, has initiated partnership discussions with an innovative company offering the latest revolution in executive air travel, a private membership model which affords entry-level flight costs at per-hour rates, and the opportunity to pay only for the hours that are flown. OMVS is exploring the possibility of sub-contracting for the carrier, offering business jet flights on its new online transportation portal now under development.

On the Move Systems, Inc. (OMVS) has established a scalable business model for leveraging the available routes and “legs” of private aviation to book private air charter, freight, and animal/exotic transport services. Their unique ISTx software is designed for managing and supporting services and routes across multiple private/commercial carriers through this single platform.

Management places strong emphasis on customer satisfaction and approaches this viewpoint by creating a unique flight or service profile for each client. The company has developed a business model offering this profile access through various proprietary and membership models. Additionally, its business strategy incorporates acquiring or joining with smaller charter plane owners. The company has further established various divisions which address particular client needs and routes. Leveraging its unique business model with a host of innovative solutions for expanding markets, OMVS is well positioned for rapid growth.

Current divisions of OMVS include Charter Services, Inter-Modal Freight, and Animal/Exotic Transport. The Charter Services Division offers private charter airplane owners the opportunity to enter a network where available planes will be "on-call" to deliver private air charter service on demand. The Inter-Modal Freight Division provides charter and freight shipping services to clients who need to expedite shipment of cargo and freight globally – including medical transport for tissue and isotopes. The company's Animal/Exotic Transport Division affords clients the security of transporting pets and animals without the accompaniment of the owner.

OMVS continues to develop technology and applications that connect all business touch points - passengers, assets, and routes. The company intends to monitor daily operations through a single platform providing ultimate support for all business activities. OMVS is in the final stages of development with the ISTx platform and plans to implement system wide in the next two fiscal quarters. Disclaimer

On the Move Systems, Inc. Company Blog

On the Move Systems, Inc. News:

OMVS Opens Partnership Talks With Innovative Jet Travel Company

OMVS Targets Growth Market in Business Jet Service

OMVS Opens Acquisition Talks

Calpian, Inc. (CLPI)

The QualityStocks Daily Newsletter would like to spotlight Calpian, Inc. (CLPI). Today, Calpian, Inc. closed trading at $1.50, up 1.35%, on 2,600 volume with 5 trades. The stock’s average daily volume over the past 60 days is 7,318, and its 52-week low/high is $0.88/$2.65.

Calpian, Inc. today announced that Chairman and Chief Executive Officer, Harold Montgomery, will be presenting at the Sixth Annual LD Micro Conference in L.A. from this December 3rd until the 5th. Mr. Montgomery will discuss the company’s domestic operations as well as the services platform of its Indian subsidiary, Money-On-Mobile, the Indian leader in pre-paid mobile payment solutions.

Calpian, Inc. (CLPI) has forged a powerful combination of steady cash flow here in the U.S. on the one hand, and explosive growth potential abroad in India on the other. Both business units are growing fast and creating huge value that has so far gone largely overlooked due to the company’s rapid rise.

Calpian is a leader in the U.S. business for providing access to credit and debit card payment processors for merchants and also for making investments in the resulting cash flow streams. Calpian's management team, with over 60 years of combined experience in payments, has also tapped into a super-hot growth opportunity in India where it is the leader in consumer payments using the cell phone - the most powerful financial trend in the developing world today. The company's revenues in India grew 300% year to year and are headed for triple digit growth again in 2013. Examples of this service in other countries like Kenya show that consumers need this simple payment tool and adopt it quickly. In Kenya, over 90% of the adult population has adopted a mobile phone money transfer system known as M-PESA, which produces over $100 million pretax profit after only 7 years in business. Calpian is providing this same service in India via Money on Mobile (MoM). India is a market at least 30 times larger than Kenya with vast potential. Calpian is the undisputed market leader in the space and looks poised to dominate the largest market for this service in the world with almost 1 billion cell phones.

In the U.S., the company has carved out a solid niche in the growing $1B plus annual residuals space for credit card usage by providing a silver bullet solution including their own gateway that merchants use to connect with large payment processors. Calpian is providing its merchant services through its wholly owned subsidiary, Calpian Commerce continues to sign merchants to card processing contracts, while Calpian itself continues acquiring additional recurring monthly cash flows from the over 10,000 smaller Independent Sales Organizations (dealers) throughout the U.S. The management team has been together for decades refining this business model through over 200 acquisitions in their careers before making it public in 2010. The team is experienced and well known throughout the industry as the go-to guys for making a deal.

In India, with Calpian acquiring an interest in March 2012 in Digital Payments Processing Limited (DPPL), which delivers the payment processing service for the Money on Mobile solution, it has taken off with incredible force, signing an incredible 53 million consumers though its vast network of 143,000 retailers (and growing at least 3,000 per month) so far. This astonishing growth is thanks in large part to how elegantly the company's mobile payment application, which is already seen as the “PayPal” of India, satisfies all the needs of the average Indian consumer, distributor, and retailer alike. The vast swathes of under-banked and unbanked consumers in India represent the tip of a much larger global iceberg for this solution as well, a solution whose backbone is simple SMS text protocol, and which bundles all the right incentives together for emerging markets. MoM is the runaway leader at this time in India pacing at 20 times larger than its nearest competitor. Disclaimer

Calpian, Inc. Company Blog

Calpian, Inc. News:

Calpian Inc. CEO Harold Montgomery to Present at the Sixth Annual LD Micro Cap Conference in Los Angeles on December 5, 2013

Calpian Inc. Subsidiary Money-on-Mobile Receives Five Year Renewal of Authorization from the Reserve Bank of India to Continue Mobile Payments System

Calpian’s Money-on-Mobile Serves Over 71 Million Users

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0045, even with yesterday's close, on 1,655,649 volume with 15 trades. The stock’s average daily volume over the past 60 days is 2,513,895, and its 52-week low/high is $0.0025/$0.029.

Singlepoint, Inc. was pleased to announce today that Moody Bible Institute will be utilizing the company's dynamic mobile donations software to enhance access to the organization's constituents and potential donors via SMS. As well, Moody will be white labeling Singlepoint's SMS Text Message Services to communicate internally and connect directly with opt-ins with potential for informational and/or marketing campaigns as well as voting and live updates.

Singlepoint, Inc. (SING) is a state-of-the-art mobile technology company and full-service mobile marketing agency. The company’s mobile commerce and communication platform allows clients to conduct business transactions, accept donations, and engage in targeted communication campaigns with their customers/donors through mobile devices.

The company is known for making any campaign instantly interactive via the mobile phone, enabling non-profit and for-profit organizations send more messages, create more awareness, and raise revenues and donations. The SinglePoint brand has been associated with media messaging campaigns for NBC, MTV, CBS, Univision and other top corporate entities.

Today, approximately 150 million web-enabled mobile phones exist in our nation alone. Javelin Strategy and Research predicts the highest growth for any payment type from now until 2018 will be in mobile payments. Rapid mobile adoption and the industry-wide push for mobile payments are anticipated to increase the total amount of mobile payments at point of sale to $5.4 billion in 2018.

SinglePoint is well positioned to capitalize on the growing mobile technology space. Key partnerships with companies such as Text2Bid, a leader in mobile auction technology, solidify the company’s foothold in the industry and provide multiple avenues for ongoing expansion. Moving forward with a solid business plan and carefully assembled management team, SinglePoint is poised for rapid growth. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

Singlepoint, Inc. Announces Moody Bible Institute to White Label Technology for Mobile Donations, SMS Capabilities

Singlepoint, Inc. and Linkstorm Form Strategic Alliance to Expand Singlepoint's Global Presence

Singlepoint, Inc. Announces Engagement of QualityStocks Investor Relations Services

GlobalWise Investments, Inc. (GWIV)

The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $0.091, even with yesterday's close. The stock’s average daily volume over the past 60 days is 29,924, and its 52-week low/high is $0.05/$0.49.

GlobalWise Investments, Inc. and its wholly owned subsidiary Intellinetics, Inc., today announced their upcoming participation in the 2013 Innovation Fair in Tokyo, Japan, from October 29th through November 1st. As a Technology United member and co-chair of its Product Roadmap Committee, Matthew Chretien, the Interim President and CEO of GlobalWise, is taking advantage of this one of a kind event to educate the market, the company's partners, as well as the dealers and manufacturers on the merits of the IntellivueGX™ platform as the ECM engine for MWAi's SAP Business One FORZA platform for the Imaging Channel.

GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.

GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.

The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.

GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer

GlobalWise Investments Company Blog

GlobalWise Investments News:

GlobalWise Announces Participation in Innovation Fair in Tokyo 2013

GlobalWise to Participate at the 2013 OPRA Fall Conference

GlobalWise to Participate at the 2013 ANCOR Technology Summit & Showcase

First Titan Corp. (FTTN)

The QualityStocks Daily Newsletter would like to spotlight First Titan Corp. (FTTN). Today, First Titan Corp. closed trading at $1.22, on 237,506 volume with 131 trades. The stock’s average daily volume over the past 60 days is 134,366, and its 52-week low/high is $0.29/$3.15.

First Titan Corp. reported today that, as the company seeks to optimize the profitability of its oil and gas assets, they are analyzing investment opportunities in digital oilfield technology as a means of reducing costs and downtime, ultimately resulting in improved operating efficiency. “The advantage of this technology is the ability to process large volumes of data types at faster speeds than conventional technology,” FTTN Interim CEO Robert Federowicz said, extolling the benefits of such technology to help keep the company out ahead of competitors and give them key insights into exploration, development, drilling and production operations quickly, as well as accurately.

First Titan Corp. (FTTN), is currently focused on exploring and developing oil and natural gas resources in the southern region of the United Sates, but has a worldwide growth strategy in place. The company continually seeks to partner with energy developers that are pursuing innovative new methods of oil and gas extraction, including the development of new technologies, cleaner methods, and unconventional resources.

First Titan has acquired multiple working interests with established oil exploration companies to deliver new hydrocarbons to an ever-growing market. As the company maintains drilling activities at its acquisition in South Lake Charles, Louisiana, it is looking to continue adding to its asset base that includes five new wells along the Gulf Coast, from West Texas to Alabama.

Global demand for energy is rising fast as the vehicle populations of emerging nations such as China, Brazil, and India continue to soar. U.S. exports of petroleum products have reached 2.6 million barrels a day, which is double the level of three years ago. As demand for global energy resources rises, the U.S. is poised to become an international supplier.

New innovations in drilling and rising global demand have positioned First Titan as a premier early-stage company with strong growth potential. By utilizing cutting-edge technology to extract oil and gas resources, the company is able to recover fossil fuels that were once considered too difficult or too expensive to recover. Disclaimer

First Titan Corp. Company Blog

First Titan Corp. News:

FTTN: Digital Oilfield Technology Opens Up Big Opportunities

FTTN: Production of Well in Alabama Exceeding Expectations

FTTN Targeting Project in Established Oilfield Undergoing Multi-Million Dollar Redevelopment

GNCC Capital, Inc. (GNCP)

The QualityStocks Daily Newsletter would like to spotlight GNCC Capital, Inc. (GNCP). Today, GNCC Capital, Inc. closed trading at $0.0005, up 25.00%, on 9,359,100 volume with 22 trades. The stock’s average daily volume over the past 60 days is 17,331,350, and its 52-week low/high is $0.0003/$0.09.

GNCC Capital, Inc. (GNCP) is a gold and silver exploration company with six different projects, all of which were carefully selected due to their outstanding characteristics. The company’s geologists will supervise an extensive exploration program for these projects to prove up reserves through geological surveys and a substantial number of carefully planned drilling programs.

The company’s initial exploration properties, located in Arizona, consist of Esther Basin, Burnt Well, Clara Gold, Kit Carson, Silverfields, and Potts Mountain. GNCC Capital plans to create significant value for its initial properties portfolio through continued exploration and joint ventures, as well as through acquiring additional gold and silver exploration assets.

GNCC Capital currently holds circa 80% of its assets in gold exploration properties. The strong rise in gold prices over recent years make this company attractive to investors seeking to benefit from the increasing value of precious metals. Backed by a world-class management team with decades of experience in the financial and mining sectors, GNCC Capital is well positioned to capitalize on the upward trend.

The company’s focus is creating value for its shareholders, employees, and business and social partners through responsible and safe exploration, mining, and marketing. While gold exploration is the company’s main focus, GNCC Capital will take advantage of value-creating opportunities in other minerals where it can leverage existing assets, skills, and experience. Disclaimer

GNCC Capital, Inc. Company Blog

GNCC Capital, Inc. News:

GNCC Capital, Inc. -- Potential Low Cost Mining at Gold Hills Property

GNCC Capital, Inc. Completes the Acquisition of the White Hills Gold Properties

GNCC Capital, Inc. Nears Completion of the Acquisition of the White Hills Gold Properties


The QualityStocks Daily Newsletter would like to spotlight PITOOEY! Inc. (PTOO). Today, PITOOEY! Inc.closed trading at $0.80, up 29.01%, on 578 volume with 2 trades. The stock’s average daily volume over the past 60 days is 4,593, and its 52-week low/high is $0.20/$1.36.

PITOOEY! Inc. (PTOO) is a digital marketing agency with proprietary technology designed to assist companies in establishing and developing a presence on the Internet. The company's offerings come from two distinct, yet synergistic, business groups, Choice One Mobile and PITOOEY!™ Mobile, with the company's flagship product, the PITOOEY!™ app.

The PITOOEY! app is a preference based, searchable ad network. Using the PITOOEY!™ platform, a partner business is able to upload broadcasts into a database, which consumers "pull" according to a profile based on their interests, previous purchases, current location, or other data. The PITOOEY! app provides businesses with a unique engagement tool while serving consumers deals, valuable content, and location-based information.

Choice One Mobile is PITOOEY!’s digital social media and marketing subsidiary, focused on developing customizable strategies that encompass each client’s unique digital marketing needs. Choice One Mobile’s vast offerings include creating and establishing a credible social media and/or Web-presence, content creation, search engine optimization, social media management, and mobile platform optimization using "Mobile Caviar" - an array of unique processes for the distribution of mobile marketing content.

PITOOEY! is putting the power to fundamentally change the nature of interaction between a business and their customers directly into the consumer’s hands via its powerful mobile and digital marketing capabilities. Leveraging its own marketing expertise to attract a crowd of businesses and consumers, the company is quickly capitalizing on a new era in communication that enables an unparalleled level of engagement between customer and merchant. Disclaimer

PITOOEY! Inc.Company Blog

PITOOEY! Inc. News:

PITOOEY!, Inc. Providing Mobile Web Platform for Frys.com Open

PITOOEY!, Inc. Provides Focused Social Media Advertising

PITOOEY!, Inc. Reports Substantial Customer Base Growth

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.4699, up 17.48%, on 160 volume with 1 trade. The stock’s average daily volume over the past 60 days is 3,956, and its 52-week low/high is $0.25/$0.95.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve.  According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months.  VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits.  In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations. 

AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data.  To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Provides Update on $36 Million Strategic Financing Agreement

VistaGen Therapeutics Presents CardioSafe 3D and LiverSafe 3D Developments at International Society of Stem Cell Research's 11th Annual Meeting

VistaGen Therapeutics and Duke University Publish Results on Production of Functional 3D Human Heart Tissue


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



FOX Penny Stocks





By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251